Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2023-06-05 Director's Dealing
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
112年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors and management, with specific numbers of shares held, pledged shares, and related percentages. It is a disclosure of insider shareholdings and pledges, typical of a Director's Dealing or insider shareholding notification. There is no indication of a full financial report, earnings release, or meeting materials. The document is relatively short (2491 characters) and focuses solely on insider shareholding data. Therefore, the best fitting category is Director's Dealing (DIRS).
2023-06-05 Chinese
112年06月僑外投資持股
Regulatory Filings Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including changes before and after a shareholders' meeting date. It includes details on share counts and categories but does not contain financial statements or management commentary. The document length is short (1060 characters) and it is a regulatory disclosure related to shareholding statistics rather than a report or announcement of voting results. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about shareholding statistics that does not fit other specific categories.
2023-06-01 Chinese
112年5月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, and changes in capital such as cash capital increase, capital surplus conversion, earnings conversion, and convertible bonds converted to common stock. It does not contain financial statements or performance data but focuses on capital changes and share capital details. The document length is short (813 characters) and appears to be a regulatory announcement about capital changes rather than a full financial report. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2023-05-19 Chinese
112年第1季海外子公司投資
Regulatory Filings Classification · 85% confidence The document is a brief financial disclosure related to investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (112年1季, which corresponds to Q1 of the 112th year in the Taiwanese calendar). The content is concise and tabular, focusing on investment details rather than a full financial report. The document length is only 664 characters, indicating it is a short disclosure rather than a comprehensive report. There is no indication that this is an announcement of a report publication or a certification. The nature of the data aligns with a short periodic financial disclosure, typical of an Interim / Quarterly Report (IR). However, given the brevity and focus on investment details without full financial statements, it is more consistent with a Regulatory Filing (RNS) as a general regulatory announcement or compliance disclosure. Therefore, the best classification is Regulatory Filings (RNS).
2023-05-10 Chinese
112年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment amounts, recognized investment gains or losses, and regulatory approval limits. The document is short (1289 characters) and primarily provides specific investment data rather than a comprehensive financial report or narrative. It does not contain full financial statements or detailed management discussion. The content aligns with regulatory disclosure requirements for cross-border investments rather than an annual or interim report, audit report, or earnings release. Given the nature and length, this document fits best as a Regulatory Filing (RNS), which serves as a general category for regulatory disclosures that do not fit other specific report types.
2023-05-10 Chinese
公告本公司國內第二次無擔保轉換公司債轉換普通股 之發行新股基準日
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement from a listed company (1786 科妍) regarding the issuance of new shares due to the conversion of domestic unsecured convertible bonds into common stock. It includes details such as the board resolution date, amount and number of shares issued, capital increase, and related procedural information. The content focuses on capital structure changes and issuance of new shares rather than a full financial report or earnings release. The document length is short (948 characters) and it is a specific announcement about share issuance. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2023-05-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.